CN107050056A - 一种阿胶组合物及其制备方法与应用 - Google Patents
一种阿胶组合物及其制备方法与应用 Download PDFInfo
- Publication number
- CN107050056A CN107050056A CN201710294479.8A CN201710294479A CN107050056A CN 107050056 A CN107050056 A CN 107050056A CN 201710294479 A CN201710294479 A CN 201710294479A CN 107050056 A CN107050056 A CN 107050056A
- Authority
- CN
- China
- Prior art keywords
- parts
- donkey
- hide gelatin
- extract
- plus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010010803 Gelatin Proteins 0.000 title claims abstract description 31
- 229920000159 gelatin Polymers 0.000 title claims abstract description 31
- 239000008273 gelatin Substances 0.000 title claims abstract description 31
- 235000019322 gelatine Nutrition 0.000 title claims abstract description 31
- 235000011852 gelatine desserts Nutrition 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims description 12
- 239000002994 raw material Substances 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 23
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 21
- 201000011510 cancer Diseases 0.000 claims abstract description 21
- 239000008280 blood Substances 0.000 claims abstract description 15
- 230000002980 postoperative effect Effects 0.000 claims abstract description 15
- 210000004369 blood Anatomy 0.000 claims abstract description 14
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 13
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 13
- 240000004307 Citrus medica Species 0.000 claims abstract description 13
- 235000001938 Citrus medica Nutrition 0.000 claims abstract description 13
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims abstract description 13
- 102000008186 Collagen Human genes 0.000 claims abstract description 13
- 108010035532 Collagen Proteins 0.000 claims abstract description 13
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 13
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 13
- 244000241872 Lycium chinense Species 0.000 claims abstract description 13
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 13
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 235000008397 ginger Nutrition 0.000 claims abstract description 13
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 12
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 12
- 244000197580 Poria cocos Species 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 12
- 210000004185 liver Anatomy 0.000 claims abstract description 12
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 7
- 235000013312 flour Nutrition 0.000 claims abstract description 7
- 244000273928 Zingiber officinale Species 0.000 claims abstract 4
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 230000006837 decompression Effects 0.000 claims description 20
- 235000009508 confectionery Nutrition 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 10
- 238000004064 recycling Methods 0.000 claims description 10
- 239000013049 sediment Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 5
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 2
- 241001251949 Xanthium sibiricum Species 0.000 claims 1
- 241000234314 Zingiber Species 0.000 description 9
- 241001247821 Ziziphus Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000005195 poor health Effects 0.000 description 2
- 238000011248 postoperative chemotherapy Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000000498 stomach carcinoma Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种阿胶组合物,由下述重量配比的原料制成:枸杞子1‑5份,菊花1‑3份,葛根3‑7份,沙棘1‑3份,胶原蛋白粉3‑7份,阿胶1‑3份,桑叶1‑3份,佛手1‑3份,茯苓2‑4份,山药粉3‑7份,决明子0.06‑0.1份,大枣1‑5份,生姜0.06‑0.1份,甘草0.03‑0.07份。该组合物合理搭配,吸收性好,具有改善睡眠、护肝、补血、癌症术后调养多种功能。
Description
技术领域
本发明涉及一种组合物,特别涉及一种用于改善睡眠、护肝、补血、癌症术后调养的组合物及其制备方法与应用。
背景技术
近年来,癌症已成为严重危害人类健康的疾病之一,被称为不治之症,是当今世界的医学难题;世界卫生组织报告显示,癌症的发病率以及死亡率逐年攀升,近三十年来,世界癌症发病率以年均3-5% 的速度递增,癌症已成为人类第一位死因。目前癌症治疗主要是以手术、化疗、放疗三种治疗措施为主,手术是治疗癌症的首选治疗办法,在做过手术之后须放化疗治疗,各类癌症手术之后在放化疗后免疫力差、气血两亏、身体虚弱、头发脱落、白细胞减少,但目前缺少一种用于癌症术后调养,可补血、护肝、改善睡眠具有多种功能的组合物。
本发明公开了一种组合物,运用辨证施治等传统中医方法,根据各种药食两用原料进行科学配比,使人体在各种原料的微量元素相互配合影响的情况下能够充分吸收,达到食补的良好效果,即冲即饮,方便食用。我公司发明创造的新产品配方搭配合理,各种原料根据其中的微量元素的化验试验结果配比而成,使人体易吸收,配合术后化疗、放疗等达到增加疗效,可有效减轻放疗化疗毒副作用,具有改善睡眠、护肝、补血、癌症术后调养多种功能。
发明内容
本发明目的在于提供一种组合物,该组合物具有改善睡眠、护肝、补血、癌症术后调养多种功能。
本发明解决其技术问题所采取的技术方案是:
本发明的一种阿胶组合物,由下述重量配比的原料制成:枸杞子1-5份,菊花1-3份,葛根3-7份,沙棘1-3份,胶原蛋白粉3-7份,阿胶1-3份,桑叶1-3份,佛手1-3份,茯苓2-4份,山药粉3-7份,决明子0.06-0.1份,大枣1-5份,生姜0.06-0.1份,甘草0.03-0. 07份。
本发明的一种阿胶组合物,优选的由下述重量配比的原料制成:枸杞子3份,菊花2份,葛根5份,沙棘2份,胶原蛋白粉5份,阿胶2份,桑叶2份,佛手2份,茯苓3份,山药粉5份,决明子0.08份,大枣3份,生姜0.08份,甘草0.05份。
本发明的一种阿胶组合物,按照常规工艺加入常规赋性制剂制成颗粒剂、丸剂、口服液、片剂、散剂。
本发明的一种阿胶组合物,由以下方法制成:
a)醇提物:按重量比取阿胶、菊花、葛根、沙棘、桑叶、佛手、茯苓、决明子、大枣和生姜,加体积百分比为50%~70%的乙醇提取两次,第一次加上述原料总重量的8倍量,提取2小时,第二次加上述原料总重量的8倍量,提取1小时,合并两次提取液,减压回收乙醇,浓缩,干燥,得醇提物;
b) 水提物:按重量比取枸杞子、甘草和山药,加水煎煮两次,第一次加上述原料总重量的8倍量,煎煮4小时,第二次加上述原料总重量的6倍量,煎煮2小时,合并两次水煎液,减压浓缩,得到50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比为60%的溶液,2-10℃静置24-48小时,滤过,弃掉沉淀,滤液减压回收乙醇,减压浓缩至50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比50%-70%醇浓度,2-10℃静置24-48小时,滤过,所得沉淀物A待用;所得滤液减压回收乙醇,浓缩,干燥,得水提物;
c)粗多糖:制备醇沉水提物过程中的沉淀物A加5倍重量的水溶解,过滤,滤液减压浓缩,干燥,得粗多糖;
d) 按重量比取胶原蛋白粉,与纯提物、水提物、粗多糖混匀即得。
本发明的一种阿胶组合物在改善睡眠、护肝、补血、癌症术后修复的应用。
本发明的有益效果是:本发明根据各种药食两用原料搭配合理,各种原料根据其中的微量元素的化验试验结果配比而成,使人体易吸收,配合术后化疗、放疗等达到增加疗效,可有效减轻放疗化疗毒副作用,具有改善睡眠、护肝、补血、癌症术后调养多种功能。
具体实施方式
实施例1 散剂
一种阿胶组合物,包括:枸杞子300g,菊花200g,葛根500g,沙棘200g,胶原蛋白粉500g,阿胶200g,桑叶200g,佛手200g,茯苓300g,山药粉500g,决明子8g,大枣300g,生姜8g,甘草5g,由以下方法制成:
a)醇提物:按重量比取阿胶、菊花、葛根、沙棘、桑叶、佛手、茯苓、决明子、大枣和生姜,加体积百分比为50%~70%的乙醇提取两次,第一次加上述原料总重量的8倍量,提取2小时,第二次加上述原料总重量的8倍量,提取1小时,合并两次提取液,减压回收乙醇,浓缩,干燥,得醇提物;
b) 水提物:按重量比取枸杞子、甘草和山药,加水煎煮两次,第一次加上述原料总重量的8倍量,煎煮4小时,第二次加上述原料总重量的6倍量,煎煮2小时,合并两次水煎液,减压浓缩,得到50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比为60%的溶液,2-10℃静置24-48小时,滤过,弃掉沉淀,滤液减压回收乙醇,减压浓缩至50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比50%-70%醇浓度,2-10℃静置24-48小时,滤过,所得沉淀物A待用;所得滤液减压回收乙醇,浓缩,干燥,得水提物;
c)粗多糖:制备醇沉水提物过程中的沉淀物A加5倍重量的水溶解,过滤,滤液减压浓缩,干燥,得粗多糖;
d) 按重量比取胶原蛋白粉,与纯提物、水提物、粗多糖混匀即得。
将组合物按照常规工艺加入常规赋性制剂制成散剂。
实施例2 颗粒剂
一种阿胶组合物,包括:枸杞子100g,菊花100g,葛根300g,沙棘100g,胶原蛋白粉300g,阿胶100g,桑叶100g,佛手100g,茯苓200g,山药粉300g,决明子6g,大枣100g,生姜6g,甘草3g,由以下方法制成:
a)醇提物:按重量比取阿胶、菊花、葛根、沙棘、桑叶、佛手、茯苓、决明子、大枣和生姜,加体积百分比为50%~70%的乙醇提取两次,第一次加上述原料总重量的8倍量,提取2小时,第二次加上述原料总重量的8倍量,提取1小时,合并两次提取液,减压回收乙醇,浓缩,干燥,得醇提物;
b) 水提物:按重量比取枸杞子、甘草和山药,加水煎煮两次,第一次加上述原料总重量的8倍量,煎煮4小时,第二次加上述原料总重量的6倍量,煎煮2小时,合并两次水煎液,减压浓缩,得到50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比为60%的溶液,2-10℃静置24-48小时,滤过,弃掉沉淀,滤液减压回收乙醇,减压浓缩至50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比50%-70%醇浓度,2-10℃静置24-48小时,滤过,所得沉淀物A待用;所得滤液减压回收乙醇,浓缩,干燥,得水提物;
c)粗多糖:制备醇沉水提物过程中的沉淀物A加5倍重量的水溶解,过滤,滤液减压浓缩,干燥,得粗多糖;
d) 按重量比取胶原蛋白粉,与纯提物、水提物、粗多糖混匀即得。
将组合物按照常规工艺加入常规赋性制剂制成颗粒剂。
实施例3 丸剂
一种阿胶组合物,包括:枸杞子500g,菊花300g,葛根700g,沙棘300g,胶原蛋白粉700g,阿胶300g,桑叶300g,佛手300g,茯苓400g,山药粉700g,决明子10g,大枣500g,生姜10g,甘草7g,由以下方法制成:
a)醇提物:按重量比取阿胶、菊花、葛根、沙棘、桑叶、佛手、茯苓、决明子、大枣和生姜,加体积百分比为50%~70%的乙醇提取两次,第一次加上述原料总重量的8倍量,提取2小时,第二次加上述原料总重量的8倍量,提取1小时,合并两次提取液,减压回收乙醇,浓缩,干燥,得醇提物;
b) 水提物:按重量比取枸杞子、甘草和山药,加水煎煮两次,第一次加上述原料总重量的8倍量,煎煮4小时,第二次加上述原料总重量的6倍量,煎煮2小时,合并两次水煎液,减压浓缩,得到50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比为60%的溶液,2-10℃静置24-48小时,滤过,弃掉沉淀,滤液减压回收乙醇,减压浓缩至50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比50%-70%醇浓度,2-10℃静置24-48小时,滤过,所得沉淀物A待用;所得滤液减压回收乙醇,浓缩,干燥,得水提物;
c)粗多糖:制备醇沉水提物过程中的沉淀物A加5倍重量的水溶解,过滤,滤液减压浓缩,干燥,得粗多糖;
d) 按重量比取胶原蛋白粉,与纯提物、水提物、粗多糖混匀即得。
将组合物按照常规工艺加入常规赋性制剂制成丸剂。
实施例4 临床试用病例典型说明:
1、某女,56 岁,患胃癌,经过胃切除手术,以肠道与食道吻合连接,做人工改造胃,手术后,身体虚弱,饮食困难,精神萎靡,乏力,食用本发明实施例1制备的散剂1个月后,精神爽硕,面色红润、体力强健,睡眠质量好,食欲正常,证本发明组合物对胃癌手术后的患者具有改善生理机能的作用,通过对该患者5 年的观察与定期检测,没有发现复发迹象。
2、某女,67 岁,患子宫癌合并卵巢癌,处于早中期,通过手术,切除子宫和卵巢,手术后体虚无力,面色苍白,没有食欲,食用本发明实施例1制备的散剂,经过2 个月,患者面色红润,睡眠良好,自我感觉身体状况较术后恢复很多,证明本组合物可补血、改善睡眠、用于癌症术后调养。
3、某男,72 岁,患结肠癌,经医院诊断后进行了结肠切除手术,并进行了人工造瘘,根据医生建议进行了放化疗,由于患结肠癌对身体造成损伤,再加上放化疗对人体的伤害,患者手术后身体状况极差,
服用本发明实施例1制备的散剂经过5 个月的服药治疗,患者身体机能得到恢复,跟踪随访患者5 年,患者仍然健壮,没有发现结肠癌复发,证明本发明药物对结肠癌患者有恢复体力和防止复发的效果。
4、某男,45 岁,患者食欲不振,血糖升高,烦躁不安,血小板减低,经医院诊断,发现该患者患有早期胰腺癌,在医生的建议下,决定切除胰腺手术,手术后进行了放化疗,由于患者胰腺切除后以及放化疗对人体生理机能造成较大的影响,所以患者精神疲惫,身体羸弱,浑身无力,服用本发明实施例1制备的散剂,经过6个月服用,患者体力大增,身体机能有所恢复,面色红润,睡眠质量好,食欲正常随访3 年后,再次诊断,患者没有其它器官转移,证明本组合物可补血、改善睡眠、用于癌症术后调养。
5、某男,56 岁,患者发现浑身无力,不思饮食,脸色黄,尿黄,到医院检查,发现患者患了早期肝癌,根据医生建议,进行肝部癌变组织切除手术,然后进行了规范放化疗治疗,患者服用本发明实施例1制备的散剂15天,面试红润,抵抗力变强,睡眠时间变长,肝部疼痛减缓,随访5 年,没有发现患者肝癌的复发和转移,证明本发明组合物对肝癌具有控制复发的效果,可有效进行癌症术后调养,具有补血、护肝、改善睡眠的功能。
治疗效果评价:
通过100 例不同类型癌症患者临床试验证明,本发明药物用于治疗癌症手术后的身体康复、补血、改善睡眠、护肝的有效率达到100%,5 年生存率达到75%,证明本发明组合物在补血、护肝、改善睡眠、用于癌症术后调养有明显功效。
上述具体实施方式仅是本发明的具体个案,本发明的专利保护范围包括但不限于上述具体实施方式的产品形态和式样,任何符合本发明且任何所属技术领域的普通技术人员对其所做的适当变化或修饰,皆应落入本发明的专利保护范围。
Claims (5)
1.一种阿胶组合物,其特征在于:由下述重量配比的原料制成:枸杞子1-5份,菊花1-3份,葛根3-7份,沙棘1-3份,胶原蛋白粉3-7份,阿胶1-3份,桑叶1-3份,佛手1-3份,茯苓2-4份,山药粉3-7份,决明子0.06-0.1份,大枣1-5份,生姜0.06-0.1份,甘草0.03-0. 07份。
2.如权利要求1所述的一种阿胶组合物,其特征在于,优选的由下述重量配比的原料制成:枸杞子3份,菊花2份,葛根5份,沙棘2份,胶原蛋白粉5份,阿胶2份,桑叶2份,佛手2份,茯苓3份,山药粉5份,决明子0.08份,大枣3份,生姜0.08份,甘草0.05份。
3.如权利要求1所述的一种阿胶组合物,其特征在于,所述的阿胶组合物按照常规工艺加入常规赋性制剂制成颗粒剂、丸剂、口服液、片剂、散剂。
4.如权利要求1或2或3所属的一种阿胶组合物,其特征在于:所述的阿胶组合物由以下方法制成:
a)醇提物:按重量比取阿胶、菊花、葛根、沙棘、桑叶、佛手、茯苓、决明子、大枣和生姜,加体积百分比为50%~70%的乙醇提取两次,第一次加上述原料总重量的8倍量,提取2小时,第二次加上述原料总重量的8倍量,提取1小时,合并两次提取液,减压回收乙醇,浓缩,干燥,得醇提物;
b) 水提物:按重量比取枸杞子、甘草和山药,加水煎煮两次,第一次加上述原料总重量的8倍量,煎煮4小时,第二次加上述原料总重量的6倍量,煎煮2小时,合并两次水煎液,减压浓缩,得到50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比为60%的溶液,2-10℃静置24-48小时,滤过,弃掉沉淀,滤液减压回收乙醇,减压浓缩至50℃下相对密度为1.05-1.15的清膏,加乙醇调成体积百分比50%-70%醇浓度,2-10℃静置24-48小时,滤过,所得沉淀物A待用;所得滤液减压回收乙醇,浓缩,干燥,得水提物;
c)粗多糖:制备醇沉水提物过程中的沉淀物A加5倍重量的水溶解,过滤,滤液减压浓缩,干燥,得粗多糖;
d) 按重量比取胶原蛋白粉,与纯提物、水提物、粗多糖混匀即得。
5.如权利要求1所述的一种阿胶组合物在改善睡眠、护肝、补血、癌症术后修复的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710294479.8A CN107050056A (zh) | 2017-04-28 | 2017-04-28 | 一种阿胶组合物及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710294479.8A CN107050056A (zh) | 2017-04-28 | 2017-04-28 | 一种阿胶组合物及其制备方法与应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107050056A true CN107050056A (zh) | 2017-08-18 |
Family
ID=59604164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710294479.8A Pending CN107050056A (zh) | 2017-04-28 | 2017-04-28 | 一种阿胶组合物及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107050056A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108434256A (zh) * | 2018-05-18 | 2018-08-24 | 杨波 | 一种养肝明目解毒排脂恢复肝脏代谢功能的中药配方 |
CN112544983A (zh) * | 2019-09-10 | 2021-03-26 | 东北农业大学 | 一种玫瑰阿胶蛋白粉及其制备方法 |
CN114698842A (zh) * | 2022-05-21 | 2022-07-05 | 于永涛 | 一种养肝护肝的参茸果组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1887330A (zh) * | 2005-06-27 | 2007-01-03 | 仁和(集团)发展有限公司 | 一种中药组合物及其制备方法和质量控制方法 |
CN103623042A (zh) * | 2013-12-06 | 2014-03-12 | 山东阿如拉药物研究开发有限公司 | 一种景天清肺药物组合物在制备抗甲型流感病毒药物中的应用 |
CN104524494A (zh) * | 2014-12-15 | 2015-04-22 | 广东梅雁吉祥水电股份有限公司 | 一种中药组合物 |
-
2017
- 2017-04-28 CN CN201710294479.8A patent/CN107050056A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1887330A (zh) * | 2005-06-27 | 2007-01-03 | 仁和(集团)发展有限公司 | 一种中药组合物及其制备方法和质量控制方法 |
CN103623042A (zh) * | 2013-12-06 | 2014-03-12 | 山东阿如拉药物研究开发有限公司 | 一种景天清肺药物组合物在制备抗甲型流感病毒药物中的应用 |
CN104524494A (zh) * | 2014-12-15 | 2015-04-22 | 广东梅雁吉祥水电股份有限公司 | 一种中药组合物 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108434256A (zh) * | 2018-05-18 | 2018-08-24 | 杨波 | 一种养肝明目解毒排脂恢复肝脏代谢功能的中药配方 |
CN112544983A (zh) * | 2019-09-10 | 2021-03-26 | 东北农业大学 | 一种玫瑰阿胶蛋白粉及其制备方法 |
CN114698842A (zh) * | 2022-05-21 | 2022-07-05 | 于永涛 | 一种养肝护肝的参茸果组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104474429A (zh) | 一种具有改善记忆力减退功能的中药制剂 | |
CN107952040A (zh) | 用于调理气郁体质的中药膏方及其加工方法 | |
JP6463504B2 (ja) | 発毛促進、脱毛緩和及び改善、血糖調節、胃腸障害の症状緩和及び改善用健康補助食品 | |
CN107050056A (zh) | 一种阿胶组合物及其制备方法与应用 | |
CN108042755A (zh) | 一种用于治疗脾胃虚弱的内服中药组合物及其应用 | |
CN102366538A (zh) | 一种补血养颜中药制剂及制备方法 | |
CN105028995A (zh) | 一种配合狗粮及其制备方法 | |
CN103721075A (zh) | 一种用于妇产科术后的中药及其制备方法 | |
CN102389562A (zh) | 一种治疗小儿积滞的中药组合物 | |
CN109528968A (zh) | 一种治疗2型糖尿病的中药组合物及其制备方法和应用 | |
CN105412798A (zh) | 小儿消积脾胃贴 | |
CN108904692A (zh) | 一种制备治疗更年期综合征的中药组合物的方法 | |
CN109223886A (zh) | 用于健脾止泻的中药组合物及其制备方法和用途 | |
CN101991829B (zh) | 一种治疗胃病的药物 | |
CN106074765A (zh) | 一种安神、助睡眠的中药组合物 | |
CN111000949A (zh) | 一种改善皮下脂肪型肥胖的组合物及其制备方法 | |
CN103719661A (zh) | 补血口服液保健品 | |
CN114306507B (zh) | 一种治疗小儿习惯性便秘的组合物及其制备方法和应用 | |
CN107898846A (zh) | 一种通过调节内分泌治疗女性黄褐斑的中药组合物 | |
CN103816484B (zh) | 一种治疗胃癌的中药组合物及其制备方法 | |
CN111053858B (zh) | 一种含中药潞党参的健脾益生保健茶及其制备方法 | |
CN107519429B (zh) | 具有改善脾胃和促进通便排毒功能的中药组合物及制法 | |
CN105343508A (zh) | 一种制备治疗更年期综合征的中药组合物的方法 | |
CN106729584A (zh) | 一种治疗小儿厌食症的中药组合物及其制备方法 | |
CN106620485A (zh) | 神曲消食口服组合物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |